BioSpace News Archive

Business

GT Medical Technologies, Inc. and Theragenics Corporation Forge Distribution Partnership for Cesium-131

GT Medical Technologies, Inc. today announced it has entered into a strategic distribution partnership with Theragenics Corporation® (Theragenics), a global leader in minimally invasive brachytherapy.

May 1, 2024
·
4 min read
Genetown

Boston Scientific Announces Upcoming Investor Conference Schedule

Boston Scientific Corporation (NYSE: BSX) will participate in two upcoming investor conferences in May.

May 1, 2024
·
1 min read
Pharm Country

Hoth Therapeutics to Attend EF Hutton Annual Global Conference, May 15, 2024

Hoth Therapeutics, Inc. is scheduled to attend the EF Hutton Annual Global Conference in New York, NY.

May 1, 2024
·
1 min read
FDA

US FDA approves high-concentration, citrate-free formulation of Cyltezo® (adalimumab-adbm) injection, Boehringer Ingelheim’s interchangeable* biosimilar to Humira®

Boehringer Ingelheim announced today that the U.S. Food and Drug Administration (FDA) has approved the high-concentration, citrate-free formulation of Cyltezo® (adalimumab-adbm), the company’s interchangeable* biosimilar to Humira® (adalimumab), to treat multiple chronic inflammatory diseases.

May 1, 2024
·
11 min read
Johnson & Johnson submits regulatory applications to European Medicines Agency for TREMFYA® (guselkumab) for treatment of patients with ulcerative colitis and Crohn’s disease

Janssen-Cilag International NV, a Johnson & Johnson company, today announced it has submitted applications to the European Medicines Agency to include the treatment of adult patients with moderately to severely active ulcerative colitis and moderately to severely active Crohn’s disease.

May 1, 2024
·
14 min read
Genetown

Ora, Inc. to showcase latest technologies and research at ARVO 2024, convene groundbreaking ophthalmic symposium Dry Horizons

Ora, Inc. announced its participation as a major exhibitor in the Association for Research in Vision and Ophthalmology 2024 conference, and as host and convener of the Dry Horizons Symposium in partnership with Ophthalmology Innovation Source.

May 1, 2024
·
5 min read
Deals

INOVIO Reports Inducement Grants Under Inducement Plan - May 1, 2024

INOVIO today announced that it has made equity grants to two newly hired employees under its 2022 Inducement Plan (the “Inducement Plan”).

May 1, 2024
·
1 min read
Genetown

Avilar Therapeutics to Present Preclinical Data for MTAC (M6PR Targeting Chimera) Extracellular Protein Degrader Platform at the American Association of Immunologists Annual Meeting

Avilar Therapeutics today announced it will present preclinical proof-of-concept data for the company’s MTAC (M6PR Targeting Chimera) protein degrader platform at IMMUNOLOGY™ 2024, the American Association of Immunologists annual meeting.

May 1, 2024
·
3 min read
Policy

Monogram Provides Regulatory Update Following Meeting with FDA

Monogram Orthopaedics Inc. today provided an update related to the regulatory and commercialization path for its mBos surgical system following its meeting with the U.S. Food and Drug Administration.

May 1, 2024
·
7 min read
Biotech Beach

Bionet America, Inc. Launches New Brio XVet Multiparameter Veterinary Monitors

Bionet America, Inc. announced the launch of the new Brio XVet series, a groundbreaking line of multiparameter monitors for use in veterinary surgery.

May 1, 2024
·
2 min read